Weekly Recap | Johnson & Johnson -5.6%, most brokers rate it buyWeekly Review·Oct 3, 2026 at 07:01 AMJNJ+1.78%
Weekly Recap | Johnson & Johnson +0.46%, most brokers rate it buyWeekly Review·Sep 26, 2026 at 06:33 AMJNJ+1.78%
Weekly Recap | Johnson & Johnson +1.66%, most brokers rate it buyWeekly Review·Sep 19, 2026 at 06:18 AMJNJ+1.78%
Weekly Recap | Johnson & Johnson -3.51%, consensus target above spotWeekly Review·Sep 12, 2026 at 06:08 AMJNJ+1.78%
Weekly Recap | Johnson & Johnson +2.68%, closing in on record highsWeekly Review·Sep 5, 2026 at 07:11 AMJNJ+1.78%
Weekly Recap | JNJ.US -0.81%, approvals fail to lift sharesWeekly Review·Aug 29, 2026 at 05:52 AMJNJ+1.78%
Weekly Recap | Johnson & Johnson +3.8%, most brokers rate it buyWeekly Review·Aug 22, 2026 at 05:11 AMJNJ+1.78%
